[Skip to Content]
[Skip to Content Landing]
Views 912
Citations 0
Invited Commentary
May 1, 2019

Small Modifications in Technique May Yield Large Rewards After Lung Cancer Surgery

Author Affiliations
  • 1Department of Surgery, The University of Chicago, Chicago, Illinois
JAMA Surg. 2019;154(7):e191014. doi:10.1001/jamasurg.2019.1014

The explanation for the development of recurrent disease, especially distant metastases, in patients with completely resected pathologic early-stage lung cancer has eluded physicians for decades. Since 2015, spread of tumor through air spaces, a previously unrecognized phenomenon, has been accepted as a mechanism of tumor recurrence after lung resection.1,2 Surgeons are increasingly familiar with molecular and genetic markers that characterize aggressive lung tumor behavior, which may suggest the need for systemic adjuvant therapy, even in patients with completely resected early-stage cancers.3

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words